The intellectual property of Med Discovery SA is administered by Katzarov SA, an Attorney Patent Office specialized in IP related to Biotechnology.
The Company has decided to focus on developing broad proprietary protection using its knowledge of development of highly specific protease inhibitors which have applications in many disease areas. Med Discovery has exploited its scientific expertise in the development of the peptabody platform, a human high avidity new molecule with mechanism of action which is of particular interest in some aggressive and hard to treat cancers.
Below is an overview of the current patent applications which have been published. Several other patents have been recently deposited (not disclosed) concerning inhibitors raised against specific oncological targets: